ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

SAXAGLIPTINUM

Active substance (INN) · ATC A10BD21 · 1 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
A10BD10	COMBINAŢII (SAXAGLIPTINUM + METFORMINUM) - concentraţia 2,5 mg/1000 mg	In force	medicine of the protocol	C2-P5	YES
A10BD21	COMBINAȚII (SAXAGLIPTIN+DAPAGLIFLOZINUM)	In force	medicine of the protocol	C2-P5	YES
A10BH03	SAXAGLIPTINUM	In force	medicine of the protocol	C2-P5	YES
A10BD08	COMBINAȚII (VILDAGLIPTIN+METFORMIN)	In force	mentioned in the text	C2-P5	YES
AE01E	PROTOCOL TERAPEUTIC ÎN DIABETUL ZAHARAT	In force	mentioned in the text	C2-P5

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
QTERN 5 mg/10 mg	COMPR. FILM.	5mg/10mg	ASTRA ZENECA AB - SUEDIA	A10BD21	PRF

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.